Market Research Logo

Hungary Pharmaceuticals & Healthcare Q4 2019

Hungary Pharmaceuticals & Healthcare Q4 2019

Key View:

Hungary's pharmaceutical market is set to continue its sluggish growth outlook, as deficiencies within public healthcarefunding continues to drag on medicine sales. The government's repressive reimbursement criteria has led to increasingcontributions from industry stakeholders, while public drug funding has stagnated. Patients will bear a rising burden of drug costs,reducing affordability and access to treatments. Nonetheless, improving public procurement practices would place downwardpressure on drug prices, thus increasing long term market sustainability as the population ages.

Key View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central & Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Hungary Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Egis Pharmaceuticals (Servier)
Gedeon Richter
Hungary Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report